{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:15:53Z","timestamp":1774440953094,"version":"3.50.1"},"reference-count":69,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Extramedullary plasma cell cancers, such as plasma cell leukaemia (PCL) and multiple extramedullary plasmacytomas (MEP) are very aggressive malignancies. These can be primary (<jats:italic>de\u2010novo<\/jats:italic>) or secondary due to progressive prior multiple myeloma (MM). Recent reports suggest an increase in incidence of these disorders. Compared to MM, organ invasion is common in PCL, while soft tissue tumors involving the head, neck or paraspinal area are common sites for MEP. Markers of poor prognosis are frequently observed in these extramedullary forms of plasma cell cancers, and survival is significantly inferior compared to patients with MM. Conventional chemotherapeutic and radiotherapy approaches have been employed with variable results. Even high dose chemotherapy with autologous stem cell rescue has not been able to demonstrate consistent improvement in survival outcome. Although not specifically evaluated, novel anti\u2010plasma cell agents, such as the proteasome inhibitor bortezomib, and immunomodulatory drugs, such as lenalidomide, appear to be active against these aggressive cancers. Clinical and translational research directed at improved understanding of disease biology and development of novel therapeutics is urgently needed.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08157.x","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T01:08:19Z","timestamp":1281920899000},"page":"418-427","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Plasma cell leukaemia and other aggressive plasma cell malignancies"],"prefix":"10.1111","volume":"150","author":[{"given":"Taimur","family":"Sher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kena C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Deeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher","family":"Chanan\u2010Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701370597"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.822"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-006-0105-5"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001617231"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701361851"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0609.1989.tb01497.x","article-title":"Plasma cell leukemia: a report on 15 patients","volume":"51","author":"Bernasconi C.","year":"1989","journal-title":"European Journal of Haematology. Supplementum"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.11.2398"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.5191061.x"},{"key":"e_1_2_6_10_1","first-page":"SCI\u20105","article-title":"Extramedullary myeloma","volume":"114","author":"Blade J.","year":"2009","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"e_1_2_6_11_1","first-page":"788","article-title":"Plasma cell leukemia following treatment with radiotherapy and melphalan","volume":"117","author":"Buskard N.A.","year":"1977","journal-title":"Canadian Medical Association Journal"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1182\/blood.V8.6.519.519","article-title":"Erythrophagocytosis in a case of plasma cell leukemia","volume":"8","author":"Butterworth C.E.","year":"1953","journal-title":"Blood"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001615710"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.5367"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.06.027"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-007-9011-5"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10297"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05114.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500520954"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2876"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.3.1032"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.5858\/2003-127-1026-DFMPCL","article-title":"Dengue fever mimicking plasma cell leukemia","volume":"127","author":"Gawoski J.M.","year":"2003","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-001-0397-4"},{"key":"e_1_2_6_24_1","first-page":"1882","article-title":"Central Nervous System and Intracranial Myeloma: a Retrospective Italian Multicenter Study","volume":"114","author":"Gozzetti A.","year":"2009","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-008-9147-4"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01510.x"},{"key":"e_1_2_6_27_1","first-page":"533","article-title":"[Plasma cell leukemia induced to complete remission with negative minimal residual disease by qualitative PCR analysis after hyper\u2010CVAD and high\u2010dose melphalan followed by autologous peripheral blood stem cell transplantation]","volume":"35","author":"Hosono N.","year":"2008","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_2_6_28_1","first-page":"428","article-title":"[IgA\u2010lambda plasma cell leukemia with gum infiltration and pleural effusion]","volume":"28","author":"Iseki T.","year":"1987","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.3322\/CA.2007.0010"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-005-0054-4"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290006143"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.11.010"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.01.036"},{"key":"e_1_2_6_34_1","first-page":"399","article-title":"[Non\u2010secretory primary plasma cell leukemia with hyperammonemia]","volume":"32","author":"Kawano F.","year":"1991","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1062391"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008310819049"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116129"},{"key":"e_1_2_6_38_1","first-page":"5057","article-title":"Incidence, clinical presentation and outcome of secondary multiple extramedullary plasmacytomas: experience at Roswell Park Cancer Institute","volume":"108","author":"Manochakian R.","year":"2006","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.2169\/naika.93.139"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705982"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1768"},{"key":"e_1_2_6_42_1","first-page":"4963","article-title":"Rapid and excellent response to hyper CVAD, particularly with thalidomide, in plasma cell leukaemia and long term remissions following allogeneic stem cell transplantation","volume":"114","author":"Murthy V.","year":"2009","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22700"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.03.013"},{"key":"e_1_2_6_45_1","first-page":"756","article-title":"[Primary plasma cell leukemia complicated with high\u2010output cardiac failure and hyperammonemia]","volume":"35","author":"Nakahashi E.","year":"1994","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90942-9"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.02.012"},{"key":"e_1_2_6_48_1","first-page":"2885","article-title":"Primary plasma cell leukemia: results of a retrospective Italian multicentric survey","volume":"114","author":"Pagano L.","year":"2009","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1159\/000210555"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401211"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403647"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404085"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190601007570"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709039043"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01134.x"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.11.1921"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20272"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03513.x"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801479"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.065"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000029713"},{"key":"e_1_2_6_62_1","first-page":"1091","article-title":"Expression of C\u2010myc p62 oncoprotein in multiple myeloma: an immunohistochemical study of 180 cases","volume":"13","author":"Skopelitou A.","year":"1993","journal-title":"Anticancer Research"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.4"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)00019-2"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<51::AID-AJH9>3.0.CO;2-0"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp329"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-002-0480-5"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2008.01037.x"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830450315"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08437.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08157.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08157.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T15:26:58Z","timestamp":1711726018000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08157.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08157.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08157.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"2010-08-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}